- Product NameAstragaloside II
- Brief DescriptionInhibitors
- Purification99.00%
- Biological ActivityAstragaloside II is a potent MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.Also, Astragaloside II induces osteogenic activities,proliferation, differentiation and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
- Target NameTGF-beta/Smad inhibitor
- CAS No. 84676-89-1
- Calculated MW 798.95
- Formulation C41H66O15
- Storage 3 years -20˚C powder;2 years -80˚C in solvent;